Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome.

Rapid shifts in the age-specific burden of malaria following successful control interventions in four regions of Uganda.

Comparison of AmpFire and MY09/11 assays for HPV genotyping in anogenital specimen of Rwandan men who have sex with men.

James Deardorff, MD

Multimodal Assessment of Biological Age Following Radiation Therapy Among Patients With Early-Stage NSCLC.

The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics.

Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association.

Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes.

Postabortion Hemorrhage and Risk of Other Complications in Women With Second-Trimester Fetal Demise.

CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma.

On-Call Junior Neurosurgery Residents Spend 9 hours of Their On-Call Shift Actively Using the Electronic Health Record.

ZSFG Department of Grand Rounds - MGR 22028

Tauheed Zaman, M.D.

Associate Clinical Professor, UCSF Department of Psychiatry

Medical Director, Opioid Safety and Addiction Consult, San Francisco VA Medical Center

Associate Director, UCSF Addition Psychiatry Fellowship

Disclosure: The Speaker and planners Elizabeth Harleman, MD; Raphaela Lipinsky Degette, MD and Adali Martinez, MD; declare they have no disclosures.

At the end of this talk, learners should be able to: 

1. Describe intra-pandemic opioid use and overdose
2. List emerging and existing treatments for opioid use disorders
3. Discuss management options in plain language with patients

Accreditation: The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  

None of the planners, [faculty, reviewers, authors, moderators, etc.] for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Designation: UCSF designates this live activity for a maximum of 64 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

The above credit is inclusive of all Fiscal year 2022 SFGH Medicine Grand rounds sessions. You must sign in to qualify for CME credit.

Zoom Information

http://tiny.ucsf.edu/DOMGrandRounds

Meeting ID: 968 1679 7792
Password: 1001
Call-in: +1 669 900 6833, +1 213 338 8477, +1 669 219 2599

Contact Information
Melody Davenport-McLaughlin
Clinical Operations
[email protected]
 

This presentation will be recorded and is accessible through My Access

https://lecture.ucsf.edu/ets/Catalog/Full/ab21c2921423425398199ec7e0720d6a2

Additive effect of AAV-mediated angiopoietin-1 and VEGF expression on the therapy of infarcted heart.

Empagliflozin in De Novo vs Acute Decompensated Chronic Heart Failure: A Prespecified Analysis From EMPULSE.